Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Georgios V. Koukourakis"'
Autor:
Demetrios Chaldeopoulos, Ivelina Beli, Andreas Fotineas, George Maravelis, Panagiotis Pantelakos, Christos Papadimitriou, Georgios Zacharias, Vassilios Kouloulias, Georgios V. Koukourakis, John Kouvaris
Publikováno v:
Molecules, Vol 14, Iss 4, Pp 1561-1577 (2009)
Malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) which have a combined incidence of 5–8/100,000 population, represent the most common primary central nervous system tumors. The treatment outcomes even with aggressive approach
Externí odkaz:
https://doaj.org/article/fff49f1cfa6243488c9f52773c453163
Autor:
John Kouvaris, Haralabos Zabatis, Georgios A. Zacharias, Michael J. Koukourakis, Vassilios Kouloulias, Georgios V. Koukourakis
Publikováno v:
Molecules, Vol 13, Iss 8, Pp 1897-1922 (2008)
Abstract: Capecitabine (Xeloda®) was developed as a pro-drug of fluorouracil (FU), with the aim of improving tolerability and intratumor drug concentrations through its tumorspecific conversion to the active drug. The purpose of this paper is
Externí odkaz:
https://doaj.org/article/619f08bf9850499c85baa31f7b0db518
Autor:
Georgios V. Koukourakis, O. Gutfeld, Carol R. Bradford, Jonathan B. McHugh, Avraham Eisbruch, Scott G. McLean, Douglas B. Chepeha, Francis P. Worden, Gregory T. Wolf, Candan Demiroz, Jeffrey M. Vainshtein, Matthew J. Schipper, Mark E. Prince
Publikováno v:
Head & Neck. 36:1589-1595
Background Management of head and neck carcinoma from unknown primary (HNCUP) remains controversial, with neck dissection and radiotherapy (RT) or definitive RT both commonly used. The purpose of this study was to characterize HNCUP and retrospective
Autor:
Georgios V, Koukourakis, Anthoula, Miliadou, Ioannis, Tsalafoutas, Myrsini G, Gkeli, Elisavet, Geli, Anastasia, Sotiropoulou-Lontou
Publikováno v:
Clinical and Translational Oncology. 15:154-159
To evaluate the impact of uterine cavity's ultrasound to final selected length of intracavitary tandem. The efficacy and tolerability of external beam radiation plus HDR-Ir(192) brachytherapy in our cohort of patients were also estimated.48 women wit
Autor:
Georgios V Koukourakis
Publikováno v:
Recent Patents on Inflammation & Allergy Drug Discovery. 6:70-77
During the last decade, the development of new drugs known as targeted therapies was the result of a better understanding of the processes involved in the transformation of normal cells into cancer. The term targeted therapy refers to drugs that sele
Publikováno v:
Clinical and Translational Oncology. 13:793-797
Ameloblastoma is known as a benign, slow-growing, rare, odontogenic neoplasm. The solid/multicystic, the unicystic with a fibrous connective-tissue capsule and the peripheral ameloblastoma represent the three well distinguished clinical types of amel
Publikováno v:
Clinical and Translational Oncology. 13:710-714
During the last decade, the development of new drugs known as targeted therapies was the result of a better understanding of the processes involved in the transformation of normal cells into cancer. The term targeted therapy refers to drugs that sele
Autor:
Georgios V. Koukourakis, Georgios Zacharias, Vassilios Kouloulias, Michael I. Koukourakis, Anastasia Sotiropoulou-Lontou
Publikováno v:
Clinical and Translational Oncology. 13:315-321
Nowadays in modern oncology there is a tendency towards therapies that target organ preservation. Organ preservation protocols have become standard in the treatment of laryngeal carcinoma, oesophageal cancer, breast carcinoma and soft tissue sarcomas
Publikováno v:
Recent Patents on Inflammation & Allergy Drug Discovery. 4:149-158
The majority of cancer patients will receive radiation therapy treatment at some stage during their malignancy. An acute skin reaction represents a common post radiation side effect with different grade of severity. In order to investigate the optima
Publikováno v:
Clinical and Translational Oncology. 12:321-325
Non-Hodgkin's lymphoma as a primary testicular neoplasm accounts approximately 9% of all testicular malignant tumours and about 1-2% of all non-Hodgkin's lymphoma. This neoplasm is the most common malignant tumour of the testis in the elderly. The mo